WF
Welch & Forbes Portfolio holdings
AUM
$8.01B
This Quarter Return
-0.93%
1 Year Return
+16.47%
3 Year Return
+86.4%
5 Year Return
+143.76%
10 Year Return
+335.97%
AUM
$3.21B
AUM Growth
-$114M
(-3.4%)
Cap. Flow
-$65.8M
Cap. Flow
% of AUM
-2.05%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
340
New
10
Increased
93
Reduced
152
Closed
8
Top Buys
| 1 |
NVIV
InVivo Therapeutics Holdings Corp
NVIV
|
$12.5M |
| 2 |
NOV
NOV
|
$4.01M |
| 3 |
Middleby
MIDD
|
$3.6M |
| 4 |
Roper Technologies
ROP
|
$2.51M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.31M |
Top Sells
| 1 |
LTM
LIFE TIME FITNESS INC
LTM
|
$20.7M |
| 2 |
Trimble
TRMB
|
$8.06M |
| 3 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
$7.81M |
| 4 |
Teradata
TDC
|
$7.59M |
| 5 |
Open Text
OTEX
|
$7.15M |
Sector Composition
| 1 | Healthcare | 20.32% |
| 2 | Technology | 14.05% |
| 3 | Industrials | 12.52% |
| 4 | Financials | 10.9% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PX
26
DELISTED
Praxair Inc
PX
| $36.6M | 1.14% |
305,889
-3,634
| -1% | -$434K |
|
27
Paychex
PAYX
$48.8B
| $36.4M | 1.13% |
775,815
-6,445
| -0.8% | -$302K |
|
28
Pfizer
PFE
$141B
| $35.9M | 1.12% |
1,127,382
-22,515
| -2% | -$716K |
|
29
Qualcomm
QCOM
$170B
| $35.6M | 1.11% |
569,177
-13,028
| -2% | -$816K |
|
30
AbbVie
ABBV
$374B
| $35.6M | 1.11% |
529,801
-10,845
| -2% | -$729K |
|
31
Gilead Sciences
GILD
$140B
| $35.1M | 1.09% |
299,996
-4,635
| -2% | -$543K |
|
32
IBM
IBM
$227B
| $35.1M | 1.09% |
225,620
-8,858
| -4% | -$1.38M |
|
33
McDonald's
MCD
$226B
| $35.1M | 1.09% |
368,698
-5,413
| -1% | -$515K |
|
34
JPMorgan Chase
JPM
$824B
| $34M | 1.06% |
501,073
-4,598
| -0.9% | -$312K |
|
35
State Street
STT
$32.1B
| $33.5M | 1.04% |
435,638
-5,894
| -1% | -$454K |
|
36
Aflac
AFL
$57.1B
| $32.9M | 1.02% |
1,056,456
-45,026
| -4% | -$1.4M |
|
37
Abbott
ABT
$230B
| $31.1M | 0.97% |
632,735
-1,212
| -0.2% | -$59.5K |
|
38
Merck
MRK
$210B
| $30.7M | 0.96% |
565,891
-8,107
| -1% | -$440K |
|
39
Chevron
CVX
$318B
| $29.4M | 0.91% |
304,555
-1,670
| -0.5% | -$161K |
|
40
Fiserv
FI
$74.3B
| $29.2M | 0.91% |
704,176
+18,044
| +3% | +$747K |
|
41
First Trust North American Energy Infrastructure Fund
EMLP
$3.3B
| $28.9M | 0.9% |
1,139,273
+36,794
| +3% | +$933K |
|
42
Intel
INTC
$105B
| $25.8M | 0.8% |
847,489
-17,402
| -2% | -$529K |
|
43
AB InBev
BUD
$116B
| $25.1M | 0.78% |
208,331
+696
| +0.3% | +$84K |
|
44
Mettler-Toledo International
MTD
$26.1B
| $24.3M | 0.75% |
71,029
+3,075
| +5% | +$1.05M |
|
45
Vertex Pharmaceuticals
VRTX
$102B
| $24M | 0.75% |
194,111
-9,853
| -5% | -$1.22M |
|
|
LLTC
46
DELISTED
Linear Technology Corp
LLTC
| $23.4M | 0.73% |
527,981
+98
| +0% | +$4.34K |
|
47
Automatic Data Processing
ADP
$121B
| $22.5M | 0.7% |
280,779
-3,929
| -1% | -$315K |
|
48
Expeditors International
EXPD
$16.3B
| $22.3M | 0.69% |
482,854
-18,981
| -4% | -$875K |
|
|
CELG
49
DELISTED
Celgene Corp
CELG
| $21.5M | 0.67% |
185,797
+1,131
| +0.6% | +$131K |
|
50
MetLife
MET
$53.6B
| $21.2M | 0.66% |
425,191
-10,255
| -2% | -$512K |
|